Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 1 / Phase 22025-01-13NCT05885464

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Beam Therapeutics Inc.8

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Cleveland Clinic- Taussig Cancer CenterClevelandUnited States1
Colorado Blood Cancer InstituteDenverUnited States178
Dana Farber and Boston Children's HospitalBostonUnited States1
Methodist Hospital - Texas Transplant InstituteSan AntonioUnited States1
OHSU Knight Cancer Institute Hematology OncologyPortlandUnited States1
Sarah Cannon- TriStar Bone Marrow TransplantNashvilleUnited States1
Stanford University School of MedicineStanfordUnited States6
The University of Kansas Cancer CenterFairwayUnited States7
University of ChicagoChicagoUnited States312